Table 3.
Physiologic System | Normal adaptation(s) to exercise training | Side effects/Symptoms of cancer treatment |
---|---|---|
Cardiovascular | ↑VO2max; ↓Resting and submaximal HR; ↓BP; ↑Plasma volume; ↑Hb | ↓VO2max; reduced exercise tolerance; ↓Hb; ↑cardiomyopathy; ↑heart disease |
Respiratory | ↓ work of breathing; ↓submaximal Ve | ↓lung capacity; ↑work of breathing; dyspnea |
Musculoskeletal | ↑ or preserve muscle CSA; ↑ muscular strength, endurance and power; ↑ or preserve BMD; ↓ bone turnover; ↑ joint ROM and lubrication | Cachexia; ↓muscle strength, endurance, power; bone loss; arthralgia; myalgia; rhabdomyolosis |
Neurologic | SNS withdrawal; improved muscle fiber recruitment; preservation of large alpha-motor neurons; improved gait and balance | Peripheral and central neuropathy; cognitive changes; loss of coordination; balance problems |
Metabolic | ↑ oxidative capacity; ↑ RMR; weight management; ↑ HDL-C; ↓LDL-C; ↓TG | Weight gain; dyslipidemia; ↓RMR |
Endocrine | ↑ insulin sensitivity; ↓ fasting BG, ↓cortisol; ↓estrogens; | Hyperinsulinemia; ↑ diabetes risk; ↓estrogens; ↓ or ↑ androgens |
Immune | Promote anti-inflammatory state | ↑IL-6, ↑IL-10; ↑CRP |
VO2max; HR; BP; Ve; CSA; BMD; ROM; SNS; RMR; HDL-C; LDL-C; TG; BG; IL-6; IL-10; CRP